Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| EROK | EAGLEROCK LAND LLC | N/A | 24,960,419 | 0.00% | 58.67% | Net Buying | Net Buying | ||
| VEL | VELOCITY FINANCIAL INC | $688.54M | 39,255,281 | 44.45% | 55.55% | Net Buying | Net Selling | ||
| MSLE | SATELLOS BIOSCIENCE INC | $118.95M | 20,831,190 | 38.33% | 0.00% | ||||
| KYMR | KYMERA THERAPEUTICS INC | $7.44B | 82,257,588 | 78.23% | 21.77% | Net Buying | Net Selling | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $504.99M | 52,276,254 | 79.90% | 20.10% | Net Buying | Net Selling | ||
| CRVO | CERVOMED INC | $39.26M | 9,258,719 | 2.43% | 97.57% | Net Buying | Net Buying | ||
| KRRO | KORRO BIO INC | $187.35M | 14,422,571 | 29.09% | 70.91% | Net Buying | Net Buying | ||
| LBRX | LB PHARMACEUTICALS INC | $860.30M | 28,676,652 | 78.33% | 21.67% | Net Buying | |||
| MMED | MINIMED GROUP INC | $4.15B | 280,819,988 | 11.35% | 88.65% | Net Selling | Net Selling | ||
| DCGO | DOCGO INC | $51.76M | 98,778,413 | 42.63% | 26.51% | Net Selling | Net Selling | ||
| WPM | WHEATON PRECIOUS METALS CORP | $55.65B | 454,044,000 | 62.05% | 0.00% | ||||
| BETA | BETA TECHNOLOGIES INC | $3.72B | 230,756,019 | 46.75% | 31.21% | Net Buying | Net Selling | ||
| ELAN | ELANCO ANIMAL HEALTH INC | $12.10B | 499,449,583 | 91.24% | 8.76% | Net Selling | Net Selling | ||
| COAG | HEMAB THERAPEUTICS HOLDINGS INC | $1.37B | 46,705,410 | 0.00% | 20.31% | Net Buying | Net Buying | ||
| CNTX | CONTEXT THERAPEUTICS INC | $58.07M | 91,879,177 | 86.17% | 1.43% | ||||
| ADTN | ADTRAN HOLDINGS INC | $1.23B | 80,998,100 | 78.26% | 21.74% | Net Selling | Net Selling | ||
| IPX | IPERIONX LTD | $1.04B | 336,322,679 | 1.29% | 0.79% | Net Buying | Net Buying | ||
| AD | ARRAY DIGITAL INFRASTRUCTURE INC | $3.36B | 86,400,000 | 22.40% | 1.00% | Net Selling | Net Buying | ||
| ACRS | ACLARIS THERAPEUTICS INC | $628.49M | 139,663,680 | 58.10% | 41.90% | Net Selling | Net Selling | ||
| ARVN | ARVINAS INC | $494.88M | 64,521,198 | 70.19% | 29.81% | Net Selling | Net Selling | ||
| ERAS | ERASCA INC | $4.25B | 310,984,542 | 76.07% | 23.93% | Net Buying | Net Buying | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $95.12M | 57,301,774 | 65.60% | 34.40% | Net Buying | |||
| WALD | WALDENCAST PLC | $212.87M | 128,237,613 | 16.70% | 13.18% | ||||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.67B | 119,828,338 | 61.89% | 38.11% | Net Buying | Net Buying | ||
| TLX | TELIX PHARMACEUTICALS LTD | $3.42B | 338,777,049 | 0.76% | 7.56% | Net Buying | Net Buying | ||
| RBRK | RUBRIK INC | $14.45B | 205,828,566 | 56.27% | 5.04% | Net Selling | Net Selling | ||
| DMRA | DAMORA THERAPEUTICS INC | $1.31B | 61,553,194 | 77.24% | 22.76% | Net Selling | |||
| IRON | DISC MEDICINE INC | $2.70B | 38,199,089 | 62.62% | 37.38% | Net Selling | Net Selling | ||
| AGMB | AGOMAB THERAPEUTICS NV | $535.13M | 48,736,779 | 47.92% | 0.09% | ||||
| CABA | CABALETTA BIO INC | $463.08M | 163,054,796 | 51.93% | 2.67% | Net Buying | |||
| AGBK | AGI INC | $1.27B | 183,566,434 | 9.05% | 2.00% | Net Buying | Net Buying | ||
| NKTR | NEKTAR THERAPEUTICS | $2.06B | 33,786,032 | 52.03% | 47.97% | Net Selling | Net Selling | ||
| LRMR | LARIMAR THERAPEUTICS INC | $378.13M | 103,882,937 | 55.87% | 44.13% | Net Buying | |||
| PHAR | PHARMING GROUP NV | $903.34M | 701,680,440 | 0.01% | 0.00% | ||||
| ALIT | ALIGHT INC | $305.69M | 537,241,981 | 73.02% | 26.98% | Net Buying | Net Buying | ||
| PCOR | PROCORE TECHNOLOGIES INC | $6.03B | 150,890,216 | 36.02% | 63.98% | Net Selling | Net Selling | ||
| AKBA | AKEBIA THERAPEUTICS INC | $287.04M | 268,258,243 | 37.91% | 8.14% | Net Selling | |||
| DSGX | DESCARTES SYSTEMS GROUP INC | $5.78B | 85,887,627 | 80.05% | 0.00% | ||||
| ELTX | ELICIO THERAPEUTICS INC | $73.48M | 19,086,081 | 13.83% | 59.76% | Net Buying | |||
| IPSC | CENTURY THERAPEUTICS INC | $413.01M | 180,354,809 | 76.61% | 23.39% | Net Selling | Net Selling | ||
| ASMB | ASSEMBLY BIOSCIENCES INC | $388.42M | 15,892,608 | 51.18% | 48.82% | Net Buying | Net Buying | ||
| MSTR | STRATEGY INC | $39.44B | 350,447,872 | 54.58% | 0.11% | Net Buying | Net Selling | ||
| IMUX | IMMUNIC INC | $193.43M | 13,621,526 | 80.09% | 19.91% | ||||
| GMAB | GENMAB A | $16.23B | 64,243,333 | 100.00% | 0.00% | ||||
| PDS | PRECISION DRILLING CORP | $1.08B | 12,932,399 | 61.59% | 0.00% | ||||
| BHVN | BIOHAVEN LTD | $2.04B | 150,560,990 | 85.71% | 14.29% | Net Buying | |||
| SABS | SAB BIOTHERAPEUTICS INC | $305.86M | 76,464,094 | 57.16% | 42.84% | Net Buying | |||
| MDXG | MIMEDX GROUP INC | $546.63M | 148,945,731 | 48.13% | 51.87% | Net Buying | Net Buying | ||
| STTK | SHATTUCK LABS INC | $379.57M | 76,680,517 | 73.12% | 19.71% | Net Buying | Net Buying | ||
| AHCO | ADAPTHEALTH CORP | $1.31B | 136,054,152 | 45.48% | 54.52% | Net Buying | Net Selling | ||
| AMBA | AMBARELLA INC | $3.07B | 43,868,185 | 71.46% | 28.54% | Net Selling | Net Selling | ||
| AVTX | AVALO THERAPEUTICS INC | $772.71M | 52,565,572 | 27.61% | 72.39% | Net Selling | Net Selling | ||
| CTKB | CYTEK BIOSCIENCES INC | $486.87M | 129,142,587 | 65.87% | 21.42% | Net Selling | Net Selling | ||
| ALM | ALMONTY INDUSTRIES INC | $4.94B | 262,776,228 | 36.74% | 0.00% | ||||
| DSGN | DESIGN THERAPEUTICS INC | $776.96M | 62,456,974 | 48.28% | 51.72% | Net Selling | |||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | $607.83M | 34,892,381 | 0.00% | 24.51% | Net Selling | Net Selling | ||
| MGPI | MGP INGREDIENTS INC | $351.34M | 21,371,237 | 25.56% | 74.44% | Net Selling | Net Selling | ||
| CPS | COOPER-STANDARD HOLDINGS INC | $529.46M | 17,755,284 | 64.85% | 19.96% | Net Selling | Net Selling | ||
| VIA | VIA TRANSPORTATION INC | $1.24B | 81,295,871 | 47.19% | 34.92% | Net Selling | Net Buying | ||
| BTGO | BITGO HOLDINGS INC | $692.28M | 115,959,409 | 30.56% | 12.83% | Net Selling | Net Selling | ||
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $214.03M | 28,423,069 | 85.46% | 12.98% | Net Buying | |||
| BKR | BAKER HUGHES CO | $57.95B | 992,068,697 | 92.39% | 0.69% | Net Selling | Net Selling | ||
| GENB | GENERATE BIOMEDICINES INC | $1.86B | 128,192,484 | 57.21% | 42.79% | Net Buying | |||
| ABVX | ABIVAX SA | $7.83B | 78,958,563 | 63.37% | 0.00% | ||||
| CCCC | C4 THERAPEUTICS INC | $458.85M | 110,567,222 | 76.42% | 18.10% | Net Selling | Net Buying | ||
| TYRA | TYRA BIOSCIENCES INC | $1.68B | 59,470,381 | 65.84% | 34.16% | Net Selling | Net Selling | ||
| AKTS | AKTIS ONCOLOGY INC | $1.29B | 53,404,618 | 52.35% | 47.65% | Net Buying | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $248.11M | 57,700,000 | 63.98% | 2.44% | Net Selling | Net Selling | ||
| EQT | EQT CORP | $31.72B | 625,478,000 | 88.26% | 11.74% | Net Selling | Net Selling | ||
| REAX | REAL BROKERAGE INC | $370.44M | 210,478,399 | 46.37% | 0.00% | ||||
| SLDB | SOLID BIOSCIENCES INC | $820.09M | 98,449,606 | 60.19% | 39.81% | Net Selling | |||
| PCVX | VAXCYTE INC | $7.43B | 144,397,682 | 89.00% | 11.00% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $923.71M | 61,458,046 | 57.24% | 42.76% | Net Buying | Net Selling | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $336.44M | 114,046,197 | 41.47% | 58.53% | Net Buying | |||
| KLRA | KAILERA THERAPEUTICS INC | $2.58B | 129,565,608 | 0.00% | 85.31% | Net Buying | Net Buying | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $830.67M | 87,347,471 | 80.05% | 19.95% | Net Selling | |||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $242.72M | 24,716,672 | 47.77% | 52.23% | Net Buying | Net Buying | ||
| KPTI | KARYOPHARM THERAPEUTICS INC | $204.42M | 22,662,943 | 33.55% | 66.45% | Net Selling | Net Selling | ||
| PARR | PAR PACIFIC HOLDINGS INC | $2.55B | 50,144,277 | 96.98% | 3.02% | Net Buying | Net Buying | ||
| OFIX | ORTHOFIX MEDICAL INC | $381.98M | 40,421,652 | 70.58% | 29.42% | Net Buying | Net Selling | ||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $238.92M | 59,880,715 | 36.74% | 63.26% | Net Buying | Net Selling | ||
| MDA | MDA SPACE LTD | $4.98B | 126,321,001 | 64.23% | 0.00% | ||||
| IVA | INVENTIVA SA | $689.86M | 193,236,978 | 27.10% | 0.00% | ||||
| SAIL | SAILPOINT INC | $7.56B | 567,182,997 | 52.78% | 47.22% | Net Selling | Net Selling | ||
| CAN | CANAAN INC | $228.34M | 10,358,912,865 | 1.40% | 3.58% | ||||
| GMRS | GMR SOLUTIONS INC | $715.66M | 54,011,711 | 0.00% | 40.82% | Net Selling | Net Buying | ||
| TENX | TENAX THERAPEUTICS INC | $318.30M | 26,525,159 | 72.85% | 27.15% | Net Buying | |||
| TBN | TAMBORAN RESOURCES CORP | $991.45M | 28,318,909 | 30.43% | 24.83% | Net Buying | Net Buying | ||
| DTIL | PRECISION BIOSCIENCES INC | $175.71M | 25,802,247 | 36.73% | 63.27% | Net Selling | |||
| JD | JDCOM INC | $37.23B | 2,701,000,000 | 6.60% | 0.48% | Net Selling | Net Selling | ||
| BCAX | BICARA THERAPEUTICS INC | $1.53B | 65,703,866 | 77.11% | 22.89% | Net Buying | Net Buying | ||
| JBIO | JADE BIOSCIENCES INC | $830.23M | 49,359,875 | 72.82% | 27.18% | Net Buying | |||
| VTVT | VTV THERAPEUTICS INC | $138.02M | 3,938,895 | 2.39% | 97.61% | Net Buying | |||
| EVMN | EVOMMUNE INC | $769.35M | 36,018,372 | 62.08% | 37.92% | Net Buying | Net Selling | ||
| GPCR | STRUCTURE THERAPEUTICS INC | $3.16B | 213,223,549 | 31.31% | 10.35% | Net Selling | |||
| REA | RARE EARTHS AMERICAS INC | $339.82M | 19,907,282 | 0.00% | 13.02% | ||||
| OVID | OVID THERAPEUTICS INC | $423.67M | 186,640,102 | 56.29% | 9.96% | Net Buying | Net Buying | ||
| ENOV | ENOVIS CORP | $1.26B | 57,562,603 | 42.40% | 57.60% | Net Selling | Net Selling | ||
| ORKA | ORUKA THERAPEUTICS INC | $4.36B | 60,312,101 | 25.55% | 74.45% | Net Buying | Net Selling | ||
| XENE | XENON PHARMACEUTICALS INC | $5.11B | 96,665,550 | 97.56% | 2.44% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.